Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Silicon Graphics, Inc. (SGI) -- Ignore unavailable to you. Want to Upgrade?

To: Ms. Baby Boomer who wrote (8093)	10/18/2000 2:19:44 PM
From: Thomas A Watson	Read Replies (1) \| Respond to of 14451

Nice piece with Mr Bishop. SGI refines its mission upside.com Tom Watson

To: Ms. Baby Boomer who wrote (8093)	10/18/2000 2:34:03 PM
From: 44magnumpower	Respond to of 14451

Thanks for INFO CONSECO rocks today! LOLOLOLOL!

To: Ms. Baby Boomer who wrote (8093)	10/18/2000 6:05:18 PM
From: 44magnumpower	Read Replies (1) \| Respond to of 14451

SGI is poised to move forward but it will take a little time. Now is the time to accumulate as we are doing. *OFF TOPIC stockhouse.com *EXACTEC "EXAC" we added to our buy list for long term it has been very strong in this lousy market. Like the children's book "The Little Engine That Could," the Exactech Corporation [EXAC] is not afraid to chug uphill and travel over a mountain or two, especially when onlookers least expect it. Like the engine in the book, Exactech's corporate strategy seems to be to exceed expectations. The onlookers, in this case, are investors and analysts--and one analyst sees a $25 stock. Exactech closed Friday at $17-1/16 a share, 47% below that expectation. Exactech closed Friday at $17-1/16 a share, 47% below that expectation. Exactech develops, sells and markets unique and competitive hip and knee replacement systems for an expanding worldwide orthopedic market. In addition, the company's first biological product, Opteform, which was co-developed with Regeneration Technologies [RTIX], is a kind of bone putty used for grafting and repairing defects in bone. Opteform was introduced in 1998, with full-scale distribution beginning only in 1999. Despite its short history, Opteform took the market by storm, and accounted for over 12% of Exactech's total sales in 1999. As it turns out, Opteform competes very successfully in the trauma market, where it is used to fill bone voids in fractures, for instance. Opteform now has plenty of competition, so in order to better satisfy its customers, President and COO Tim Seese said that the company took on a complementary line of products to better support Opteform in the marketplace. That complementary line comes from an exclusive distribution agreement with the German company Aap Implantate AG, which manufactures products that replace damaged joints and ones that temporarily aid in the healing of bone fractures. Products with names such as Biorigid tibial nails and cannulated screws sound very unappetizing, but are absolutely necessary in order to keep the human skeleton intact after an injury. A total of 146 sales reps will chase this market, which William Plovanic of PMG Capital estimates to be $670 million annually. These added sales are due to kick in slowly. According to Seese, not only will they be a profit center, they'll also stimulate Opteform sales to higher levels. Opteform sales growth has slowed recently. "The big rollout this year is in our hip implant line." No such slowdown is being experienced in the hip and knee markets, however. According to Seese, "The big rollout this year is in our hip implant line. And it's called the AcuMatch hip implant system and there are several component parts of that system." The rollout began at the American Academy of Orthopedics earlier this year and will continue until year-end. As unglamorous as it sounds, the AcuMatch Hip System improves the patient's range of motion in an attempt to restore complete mobility. The one negative on the horizon for Exactech is its dispute with Opteform's co-developer, Regeneration Technologies. Exactech claims that RTIX is encroaching on its marketing territory in violation of their agreement. The case is before arbitration and is proceeding at a snail's pace. The management team at Exactech is slowly but surely engineering products that keep a rapidly aging population mobile. Exactech's products are considered to be among the best in the business. Preserving an active lifestyle is a worthy goal, and everyone knows what a large market that is. 44Magnums Holdings CNC EXAC SGI TTIL